Clinical Trial Update: Aspirin Attenuates Inflammation in Human Cerebral Aneurysms [Phase 1]

View source ↗

Summary

Phase 1 study evaluating aspirin's ability to attenuate inflammation in unruptured cerebral aneurysms. The trial used MRI biomarkers and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Unruptured Cerebral Aneurysm

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: University of Iowa | Conditions: The Focus of the Study is to Monitor MRI Signal Changes and Inflammatory Biomarkers With Use of Aspirin in Patients With Unruptured Cerebral Aneurysm | Phase 1 | Status: COMPLETED